Combining CAL-101 with celecoxib enhances apoptosis of EBV-transformed B-cells through MAPK-induced ER stress

Anticancer Research

Volumn 35, Issue 5, 2015, Pages 2699-2708

  Park, Ga Bin ^a   Hur, Dae Young ^a   Kim, Daejin ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

CAL 101; Celecoxib; EBV transformed B cells; ER stress

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; APOPTOSIS SIGNAL REGULATING KINASE 1; BIM PROTEIN; CASPASE 3; CASPASE 9; CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN HOMOLOGOUS PROTEIN; CELECOXIB; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IDELALISIB; INITIATION FACTOR 2ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHORYLATED PROTEIN KINASE RNA LIKE ENDOPLASMIC RETICULUM KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE; PROTEIN KINASE B; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE 1; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE 2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SALUBRINAL; UNCLASSIFIED DRUG; CYCLOOXYGENASE 2; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PTGS2 PROTEIN, HUMAN; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE; QUINAZOLINONE DERIVATIVE; SULFONAMIDE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DAUDI CELL LINE; DOWN REGULATION; DRUG CYTOTOXICITY; ENDOPLASMIC RETICULUM STRESS; ENZYME PHOSPHORYLATION; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPHOMA CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAJI CELL LINE; RESAZURIN ASSAY; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG EFFECTS; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; B-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; CYCLOOXYGENASE 2; ENDOPLASMIC RETICULUM STRESS; HERPESVIRUS 4, HUMAN; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PURINES; PYRAZOLES; QUINAZOLINONES; SIGNAL TRANSDUCTION; SULFONAMIDES;

EID: 84929676288     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M and Bilanges B: The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 11: 329-341, 2010.
2. Geering B, Cutillas PR and Vanhaesebroeck B: Regulation of class IA PI3Ks: is there a role for monomeric PI3K subunits? Biochem Soc Trans 35(Pt 2): 199-203, 2007.
3. Bilancio A, Okkenhaug K, Camps M, Emery JL, Ruckle T, Rommel C and Vanhaesebroeck B. Key role of the p110δ isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110δ function in B-cells. Blood 107: 642-650, 2006.
4. Simpson L, Parsons R. PTEN: life as a tumor suppressor. Exp Cell Res 264: 29-41, 2001.
5. Papakonstanti EA, Ridley AJ and Vanhaesebroeck B: The p110δ isoform of PI3-kinase negatively controls RHOA and PTEN. EMBO J 26: 3050-3061, 2007.
6. Chang J, Xie M, Shah VR, Schneider MD, Entman ML, Wei L and Schwartz RJ: Activation of RHO-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis. Proc Natl Acad Sci USA 103: 14495-14500, 2006.
7. Furukawa N, Ongusaha P, Jahng WJ, Araki K, Choi CS, Kim HJ, Lee YH, Kaibuchi K, Kahn BB, Masuzaki H, Kim JK, Lee SW and Kim YB: Role of RHO-kinase in regulation of insulin action and glucose homeostasis. Cell Metab 2: 119-129, 2005.
8. Castillo JJ, Furman M and Winer ES: CAL-101: a phosphatidylinositol-3-kinase p110-δ inhibitor for the treatment of lymphoid malignancies. Expert Opin Investig Drugs 21: 15-22, 2012.
9. Ikeda H, Hideshima T, Fulciniti M, Perrone G, Miura N, Yasui H, Okawa Y, Kiziltepe T, Santo L, Vallet S, Cristea D, Calabrese E, Gorgun G, Raje NS, Richardson P, Munshi NC, Lannutti BJ, Puri KD, Giese NA and Anderson KC: PI3K/p110δ is a novel therapeutic target in multiple myeloma. Blood 116: 1460-1468, 2010.
10. Sarkar FH, Adsule S, Li Y and Padhye S: Back to the future: COX2 inhibitors for chemoprevention and cancer therapy. Mini Rev Med Chem 7: 599-608, 2007.
11. Wun T, McKnight H and Tuscano JM: Increased cyclooxygenase-2 (COX2): a potential role in the pathogenesis of lymphoma. Leuk Res 28: 179-190, 2004.
12. Jendrossek V, Handrick R and Belka C: Celecoxib activates a novel mitochondrial apoptosis signaling pathway. FASEB J 17: 1547-1549, 2003.
13. Subhashini J, Mahipal SV and Reddanna P: Antiproliferative and apoptotic effects of celecoxib on human chronic myeloid leukemia in vitro. Cancer Lett 224: 31-43, 2005.
14. Chen ST, Thomas S, Gaffney KJ, Louie SG, Petasis NA and Schönthal AH: Cytotoxic effects of celecoxib on Raji lymphoma cells correlate with aggravated endoplasmic reticulum stress but not with inhibition of cyclooxygenase-2. Leuk Res 34: 250-253, 2010.
15. Tsutsumi S, Gotoh T, Tomisato W, Mima S, Hoshino T, Hwang HJ, Takenaka H, Tsuchiya T, Mori M and Mizushima T: Endoplasmic reticulum stress response is involved in nonsteroidal anti-inflammatory drug-induced apoptosis. Cell Death Differ 11: 1009-1016, 2004.
16. Cusimano A, Azzolina A, Iovanna JL, Bachvarov D, McCubrey JA, D'Alessandro N, Montalto G and Cervello M: Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle 9: 1399-1410, 2010.
17. Setia S, Nehru B and Sanyal SN: The PI3K/AKT pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a COX2-selective inhibitor. Biomed Pharmacother 68: 721-727, 2014.
18. Hyoda K, Hosoi T, Horie N, Okuma Y, Ozawa K and Nomura Y: PI3K-AKT inactivation induced CHOP expression in endoplasmic reticulum-stressed cells. Biochem Biophys Res Commun 340: 286-290, 2006.
19. Park GB, Kim YS, Lee HK, Song H, Cho DH, Lee WJ and Hur DY: Endoplasmic reticulum stress-mediated apoptosis of EBV-transformed B-cells by cross-linking of CD70 is dependent upon generation of reactive oxygen species and activation of p38 MAPK and JNK pathway. J Immunol 185: 7274-7284, 2010.
20. Keniry M and Parsons R: The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 27: 5477-5485, 2008.
21. Park GB, Kim YS, Lee HK, Song H, Kim S, Cho DH and Hur DY: Reactive oxygen species and p38 MAPK regulate BAX translocation and calcium redistribution in salubrinal-induced apoptosis of EBV-transformed B-cells. Cancer Lett 313: 235-248, 2011.
22. Mhaidat NM, Thorne R, Zhang XD and Hersey P: Involvement of endoplasmic reticulum stress in docetaxel-induced JNK-dependent apoptosis of human melanoma. Apoptosis 13: 1505-1512, 2008.
23. Al-Alwan MM, Okkenhaug K, Vanhaesebroeck B, Hayflick JS and Marshall AJ: Requirement for phosphoinositide 3-kinase p110δ signaling in B-cell antigen receptor-mediated antigen presentation. J Immunol 178: 2328-2335, 2007.
24. Jou ST, Carpino N, Takahashi Y, Piekorz R, Chao JR, Carpino N, Wang D and Ihle JN: Essential, nonredundant role for the phosphoinositide 3-kinase p110δ in signaling by the B-cell receptor complex. Mol Cell Biol 22: 8580-8591, 2002.
25. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F and Wymann MP: Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287: 1049-1053, 2000.
26. Pauls SD, Lafarge ST, Landego I, Zhang T and Marshall AJ: The phosphoinositide 3-kinase signaling pathway in normal and malignant B-cells: activation mechanisms, regulation and impact on cellular functions. Front Immunol 3: 224, 2012.
27. Gallouet AS, Travert M, Bresson-Bepoldin L, Guilloton F, Pangault C, Caulet-Maugendre S, Lamy T, Tarte K and Guillaudeux T: COX2-independent effects of celecoxib sensitize lymphoma B-cells to TRAIL-mediated apoptosis. Clin Cancer Res 20: 2663-2673, 2014.
28. Liang SH, Zhang W, McGrath BC, Zhang P and Cavener DR: PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis. Biochem J 393(Pt 1): 201-209, 2006.
29. Liu M, Li CM, Chen ZF, Ji R, Guo QH, Li Q, Zhang HL and Zhou YN: Celecoxib regulates apoptosis and autophagy via the PI3K/AKT signaling pathway in SGC-7901 gastric cancer cells. Int J Mol Med 33: 1451-1458, 2014.
30. Price J, Zaidi AK, Bohensky J, Srinivas V, Shapiro IM and Ali H: AKT-1 mediates survival of chondrocytes from endoplasmic reticulum-induced stress. J Cell Physiol 222: 502-508, 2010.
31. Song S, Chew C, Dale BM, Traum D, Peacock J, Yamazaki T, Clynes R, Kurosaki T and Greenberg S: A requirement for the p85 PI3K adapter protein BCAP in the protection of macrophages from apoptosis induced by endoplasmic reticulum stress. J Immunol 187: 619-625, 2011.
32. Iyengar S, Clear A, Bödör C, Maharaj L, Lee A, Calaminici M, Matthews J, Iqbal S, Auer R, Gribben J and Joel S: P110δ-mediated constitutive PI3K signaling limits the efficacy of p110α-selective inhibition in mantle cell lymphoma, particularly with multiple relapse. Blood 121: 2274-2284, 2013.
33. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A and Ichijo H: ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16: 1345-1355, 2002.
34. Zheng QY, Li PP, Jin FS, Yao C, Zhang GH, Zang T and Ai X: Ursolic acid induces ER stress response to activate ASK1-JNK signaling and induce apoptosis in human bladder cancer T24 cells. Cell Signal 25: 206-213, 2013.